ES460411A2 - Procedimiento de preparacion de derivados arilamino-pirimi- dinicos. - Google Patents

Procedimiento de preparacion de derivados arilamino-pirimi- dinicos.

Info

Publication number
ES460411A2
ES460411A2 ES460411A ES460411A ES460411A2 ES 460411 A2 ES460411 A2 ES 460411A2 ES 460411 A ES460411 A ES 460411A ES 460411 A ES460411 A ES 460411A ES 460411 A2 ES460411 A2 ES 460411A2
Authority
ES
Spain
Prior art keywords
preparation
derivatives
arylaminopyrimidine
therapeutics
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460411A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7620775A external-priority patent/FR2357252A2/fr
Priority claimed from FR7718471A external-priority patent/FR2394543A2/fr
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES460411A2 publication Critical patent/ES460411A2/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

Mejoras introducidas en el objeto de la patente principal Nº 429.869, concedida el 27 de Marzo de 1976: Procedimiento de preparación de derivados arilamino-pirimidínicos¿¿, refiriéndose dichas mejoras a un procedimiento de preparación de los compuestos que responden a la fórmula ***
ES460411A 1976-07-07 1977-07-05 Procedimiento de preparacion de derivados arilamino-pirimi- dinicos. Expired ES460411A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7620775A FR2357252A2 (fr) 1976-07-07 1976-07-07 Nouveaux derives arylaminopyrimidiniques, leur procede de preparation et leur application en therapeutique
FR7718471A FR2394543A2 (fr) 1977-06-16 1977-06-16 Nouveaux derives arylaminopyrimidiniques, leur procede de preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES460411A2 true ES460411A2 (es) 1978-10-01

Family

ID=26219529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES460411A Expired ES460411A2 (es) 1976-07-07 1977-07-05 Procedimiento de preparacion de derivados arilamino-pirimi- dinicos.

Country Status (11)

Country Link
JP (1) JPS5312877A (es)
AU (1) AU2680877A (es)
CH (1) CH611283A5 (es)
DE (1) DE2729360A1 (es)
ES (1) ES460411A2 (es)
GB (1) GB1548858A (es)
IT (1) IT1114810B (es)
LU (1) LU77660A1 (es)
NL (1) NL7707531A (es)
SE (1) SE7707880L (es)
SU (1) SU679143A3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005047268A2 (en) * 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use

Also Published As

Publication number Publication date
SE7707880L (sv) 1978-01-08
DE2729360A1 (de) 1978-01-12
JPS5312877A (en) 1978-02-04
NL7707531A (nl) 1978-01-10
LU77660A1 (es) 1978-01-27
SU679143A3 (ru) 1979-08-05
GB1548858A (en) 1979-07-18
CH611283A5 (en) 1979-05-31
AU2680877A (en) 1979-01-11
IT1114810B (it) 1986-01-27

Similar Documents

Publication Publication Date Title
ES452942A1 (es) Procedimiento para la produccion de dihidrociclosporina c.
ES282833A1 (es) Procedimiento para la aclaración óptica de materiales orgánicos
ES458176A1 (es) Procedimiento para la preparacion de derivados de indazolil-(4)-oxi-propanolamina.
ES432334A1 (es) Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.
ES460411A2 (es) Procedimiento de preparacion de derivados arilamino-pirimi- dinicos.
ES462849A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
JPS53143422A (en) Back mark detector
ES458389A1 (es) Procedimiento para preparar derivados de prostaglandina.
ES445981A1 (es) Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na.
ES462844A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
ES360861A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazepina.
ES459304A2 (es) Perfeccionamientos en la fabricacion de dispositivos aplica-bles a munequeria simuladores de funciones fisiologicas.
ES457780A1 (es) Un procedimiento para la obtencion de 7,10-dimetil-5,9-imi- no-4,5,8,9 - tetrahidrocicloocta (b) tiofenos.
ES449841A1 (es) Procedimiento de preparacion de nuevos derivados de la 7h- indolizino (7, 6, 5-de) isoquinoleina.
ES457089A1 (es) Procedimiento para la preparacion de nuevos colorantes basi-cos de antraquinona.
JPS5367083A (en) Extreme position setting for nc machine
JPS51146390A (en) Process for production of chromium sesquioxide
ES461174A1 (es) Procedimiento para la preparacion de 3-azidometil-2,9-dioxa-triciclo (4,3,1,0 3,7) decanos.
ES450882A2 (es) Procedimiento de preparacion de nuevos compuestos tetrahi- dropirimidinicos.
ES477320A1 (es) Procedimiento para la produccion de derivados de ciclospori-na.
ES461324A1 (es) Un procedimiento para la preparacion de d-homoesteroides.
ES460297A1 (es) Un compuesto.
ES453556A1 (es) Procedimiento para la preparacion de n-fenil-5-cloro-2-ni- troanilina.
ES386485A2 (es) Un procedimiento de preparacion de nuevos alcoholes haloge-nados.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170706